Advanced Vaccinology Course (ADVAC)

• Objective: annual

• Frequency: 2 weeks

• Registration fees: 3,800 euros (Participants from academic / governmental institutions and NGOs benefit from reduced fees: 1,400 euros)

Target

Scientists and decision-makers involved in vaccine development, in the elaboration of new vaccination strategies or in policy decisions related to the introduction of new vaccines in public health programmes, at national or international levels. For both, public and private sectors.

Objectif

To facilitate critical decision making in vaccinology by providing participants with a comprehensive overview of the field, from immunology to vaccine development, including clinical trials and the social, economic, political and ethical issues of vaccination.

• ADVAC Network

• ADVAC website

Partners

• Bill & Melinda Gates Foundation

• Centers for Disease Control (CDC)

• Crucell Berna Biotech

• European Centre for Disease Prevention and Control (ECDC)

• European Commission/p>

• European Society for Paediatric Infectious Diseases (ESPID)

• GlaxoSmithKline

• Johns Hopkins Bloomberg School of Public Health

• Merck

• National Foundation for Infectious Diseases (NFID)

• National Institute of Allergy and Infectious Diseases (NIAID)

• National Vaccine Programme Office (NVPO)

• Novartis Vaccines

• Pfizer

• Sanofi Pasteur

• Sanofi Pasteur MSD

• Shantha

• University of Geneva

• Vaxinnate

• World Health Organization (WHO)

Contact

Katia Mielczarek
Training Programmes Coordinator

Tel : +33 (0)4 72 40 79 45
E-mail : Send an e-mail